Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Enteral Lactoferrin for the Treatment of Sepsis and Necrotizing Enterocolitis in Neonates." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438797/1/Antiplatelet_and_anticoagulant_agents_for_primary_prevention_of_thrombosis_in_individuals_with_antiphospholipid_antibodies_New. Accessed 24 April 2024.
Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438797/1/Antiplatelet_and_anticoagulant_agents_for_primary_prevention_of_thrombosis_in_individuals_with_antiphospholipid_antibodies_New. Accessed April 24, 2024.
Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438797/1/Antiplatelet_and_anticoagulant_agents_for_primary_prevention_of_thrombosis_in_individuals_with_antiphospholipid_antibodies_New
Enteral Lactoferrin for the Treatment of Sepsis and Necrotizing Enterocolitis in Neonates [Internet]. In: Cochrane Abstracts. [cited 2024 April 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438797/1/Antiplatelet_and_anticoagulant_agents_for_primary_prevention_of_thrombosis_in_individuals_with_antiphospholipid_antibodies_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates
ID - 438797
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438797/1/Antiplatelet_and_anticoagulant_agents_for_primary_prevention_of_thrombosis_in_individuals_with_antiphospholipid_antibodies_New
DB - Evidence Central
DP - Unbound Medicine
ER -